Aaron Frank Bartlone, executive of Helus Pharma Inc. (formerly, Cybin Inc.) (NEO:HELP), sold 51,184 Common Shares on the open market at an average of US$10.54, a US$539K sale (about C$762K) on Oct 19, 2026.
The sale reduced the direct holding by about 23%. Bartlone now holds 173,970 shares directly, worth about C$2.6M at the Oct 16, 2026 close.
HELP closed at C$14.95 on Oct 16, 2026, up 50% over the prior three months. In the 52 weeks to that date it closed between C$5.49 and C$19.71.
